Literature DB >> 12872793

Iris transillumination defects in patients with primary open angle glaucoma.

R Christen1, M Pache, B Teuchner, P Meyer, C Prünte, J Flammer.   

Abstract

PURPOSE: To examine the incidence and pattern of iris transillumination defects in patients with primary open angle glaucoma (POAG) with and without vascular dysregulation, in comparison to controls.
METHODS: We prospectively examined 24 patients with POAG (M/F 10:14; mean age 59 +/- 14, range 21-76 years) and 23 controls (M/F 10:13; mean age 52 +/- 15, range 25-86 years). Vascular dysregulation was presumed if patients had a typical medical history of vasospasm and a pathological result in nailfold capillaroscopy. Iris transillumination defects were visualized by video-taped, digitized diaphanoscopy and assessed by two blinded observers.
RESULTS: We found significantly more iris transillumination defects in POAG than in controls (54.2% vs. 8.7%; chi2 = 8.85; df = 1; p = 0.002). The defects in POAG showed a characteristic radially-streaked pattern different from those described, for instance, in pigment dispersion syndrome, pseudoexfoliation syndrome, and acute glaucoma. Glaucoma patients with vascular dysregulation had a tendency to a higher incidence of transillumination defects than non-vasospastic patients, though this finding was not significant.
CONCLUSIONS: Patients with POAG have a higher incidence of iris transillumination defects than controls. The underlying mechanisms are not yet clear and call for further investigation.

Entities:  

Mesh:

Year:  2003        PMID: 12872793     DOI: 10.1177/112067210301300406

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

Review 1.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

2.  Clinical diagnosis of presumed SOX2 gonadosomatic mosaicism.

Authors:  Malena Daich Varela; Robert B Hufnagel; Bin Guan; Delphine Blain; Julie C Sapp; Andrea L Gropman; Ramakrishna Alur; Jennifer J Johnston; Leslie G Biesecker; Brian P Brooks
Journal:  Ophthalmic Genet       Date:  2021-03-15       Impact factor: 1.274

3.  An ocular glymphatic clearance system removes β-amyloid from the rodent eye.

Authors:  Xiaowei Wang; Nanhong Lou; Allison Eberhardt; Yujia Yang; Peter Kusk; Qiwu Xu; Benjamin Förstera; Sisi Peng; Meng Shi; Antonio Ladrón-de-Guevara; Christine Delle; Björn Sigurdsson; Anna L R Xavier; Ali Ertürk; Richard T Libby; Lu Chen; Alexander S Thrane; Maiken Nedergaard
Journal:  Sci Transl Med       Date:  2020-03-25       Impact factor: 17.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.